CVS Health Corp (NYSE: CVS) kicked off on Tuesday, up 2.23% from the previous trading day, before settling in for the closing price of $76.53. Over the past 52 weeks, CVS has traded in a range of $43.56-$85.15.
During the last 5-year period, the sales drop of Healthcare Sector giant was -6.37%. While this was happening, its average annual earnings per share was recorded 22.57%. With a float of $1.27 billion, this company’s outstanding shares have now reached $1.27 billion.
CVS Health Corp (CVS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of CVS Health Corp is 0.15%, while institutional ownership is 89.04%. The most recent insider transaction that took place on Aug 20 ’25, was worth 532,650. In this transaction Director of this company sold 7,500 shares at a rate of $71.02, taking the stock ownership to the 22,156 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director proposed sale 7,500 for $70.97, making the entire transaction worth $532,275.
CVS Health Corp (CVS) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 1.19 earnings per share (EPS), higher than consensus estimate (set at 0.92) by 0.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.72% during the next five years compared to -6.37% drop over the previous five years of trading.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Take a look at CVS Health Corp’s (CVS) current performance indicators. Last quarter, stock had a quick ratio of 0.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25. Likewise, its price to free cash flow for the trailing twelve months is 15.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.38, a number that is poised to hit 0.98 in the next quarter and is forecasted to reach 7.18 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
Looking closely at CVS Health Corp (NYSE: CVS), its last 5-days average volume was 9.19 million, which is a jump from its year-to-date volume of 9.06 million. As of the previous 9 days, the stock’s Stochastic %D was 38.44%.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 74.07%, which indicates a significant increase from 59.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.92 in the past 14 days, which was higher than the 1.77 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $78.72, while its 200-day Moving Average is $69.82. However, in the short run, CVS Health Corp’s stock first resistance to watch stands at $79.76. Second resistance stands at $81.27. The third major resistance level sits at $82.05. If the price goes on to break the first support level at $77.47, it is likely to go to the next support level at $76.69. Should the price break the second support level, the third support level stands at $75.18.
CVS Health Corp (NYSE: CVS) Key Stats
The company with the Market Capitalisation of 99.32 billion has total of 1,269,432K Shares Outstanding. Its annual sales at the moment are 372,809 M in contrast with the sum of 4,614 M annual income. Company’s last quarter sales were recorded 102,871 M and last quarter income was -3,975 M.
